Atlas Trials

Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen

Clinical trial NCT01587040 · COMPLETED

Trial details

NCT number
NCT01587040
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Neoplasm Malignant
Start date
2012-07-20
Primary completion
2018-05-23
Enrollment
61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.